title: In vivo stimulation of early peripheral axon regeneration by N-propionylmannosamine in the presence of polysialyltransferase ST8SIA2.
abstract: The key enzyme of sialic acid (Sia) biosynthesis is the bifunctional UDP-N-acetylglucosamine 2-epimerase/ManNAc kinase (GNE/MNK). It metabolizes the physiological precursor ManNAc and N-acyl modified analogues such as N-propionylmannosamine (ManNProp) to the respective modified sialic acid. Polysialic acid (polySia) is a crucial compound for several functions in the nervous system and is synthesized by the polysialyltransferases ST8SIA2 and ST8SIA4. PolySia can be modified in vitro and in vivo by metabolic glycoengineering of the N-acyl side chain of Sia. In vitro studies show that the application of ManNProp increases neurite outgrowth and accelerates the re-establishment of functional synapses. In this study, we investigate in vivo how ManNProp application might benefit peripheral nerve regeneration. In mice expressing axonal fluorescent proteins (thy-1-YFP), we transected the sciatic nerve and then replaced part of it with a sciatic nerve graft from non-expressing mice (wild-type mice or St8sia2(-/-) mice). Analyses conducted 5 days after grafting showed that systemic application of ManNProp (200 mg/kg, twice a day, i.p.), but not of physiological ManNAc (1 g/kg, twice a day, i.p.), significantly increased the extent of axonal elongation, the number of arborizing axons and the number of branches per regenerating axon within the grafts from wild-type mice, but not in those from St8sia2(-/-) mice. The results demonstrate that the application of ManNProp has beneficial effects on early peripheral nerve regeneration and indicate that the stimulation of axon growth depends on ST8SIA2 activity in the nerve graft.
authors: Klinik für Plastische und Handchirurgie, Universitätsklinikum Freiburg, Freiburg, Germany, georgios.koulaxouzidis@uniklinik-freiburg.de.
authors: Georgios
authors: G
authors: Koulaxouzidis
authors: Werner
authors: W
authors: Reutter
authors: Herbert
authors: H
authors: Hildebrandt
authors: G Björn
authors: GB
authors: Stark
authors: Christian
authors: C
authors: Witzel
mesh_terms: D000818:Animals; D001369:Axons / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D048429:Cell Size; D004195:Disease Models, Animal; D005260:Female; D006595:Hexosamines / Q000494:pharmacology*; D053208:Kaplan-Meier Estimate; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D008297:Male; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009416:Nerve Regeneration / Q000187:drug effects* / Q000502:physiology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D012584:Sciatic Nerve / Q000293:injuries* / Q000503:physiopathology / Q000601:surgery / Q000637:transplantation; D012799:Sialyltransferases / Q000235:genetics / Q000378:metabolism*; D019737:Transplants; D016896:Treatment Outcome
chemical_list: D001426:Bacterial Proteins; D006595:Hexosamines; D008164:Luminescent Proteins; C415828:N-propionylmannosamine; D018696:Neuroprotective Agents; C054562:yellow fluorescent protein, Bacteria; C046778:CMP-N-acetylneuraminate-poly-alpha-2,8-sialosyl sialyltransferase; D012799:Sialyltransferases